• search

Actavis expands its operations in India

Written by: Staff

Mumbai, Mar 3: Iceland-based pharma major Actavis group has opened new premises for its subsidiary Lotus Labs, at Koramangala in Bangalore.

The new premises with a total area of 3,000 sq metres, will house offices, laboratories and facilities for clinical bio-equivalence studies besides employing about 200-300 personnel in its production plant.

Actavis, the generic drugs company has invested around 20 million Euros in Lotus Labs, an official release here stated.

During the past year, Actavis has greatly expanded its operations in India and has entered into partnership agreements with three Indian pharma companies-- Emcure, Shasun and Orchid, the release added.


For Daily Alerts
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more